Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: MRVI

Maravai LifeSciences Holdings, Inc.

Healthcare | Biotechnology

No licensed closing price on file for MRVI. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-0.52

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 15:50 UTC.

What Maravai LifeSciences Holdings, Inc. does

Maravai LifeSciences is a life sciences company that provides products and services to support the development of drugs, therapeutics, vaccines, and diagnostics. The company operates through two segments: TriLink, which produces complex nucleic acids including mRNA, oligonucleotides, and specialty enzymes for therapeutic and diagnostic applications; and Cygnus, which offers biologics safety testing products designed to detect impurities in biopharmaceutical manufacturing.

Summarized from Maravai LifeSciences Holdings, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (TTM)$-0.52
Debt/equity0.72

Revenue, margins & earnings

FY2021 Net income: $182MFY2021 Taxes & interest: $373MFY2021 Operating costs: $245M$799MFY2021FY2022 Net income: $220MFY2022 Taxes & interest: $354MFY2022 Operating costs: $309M$883MFY2022FY2023: net loss $119M on revenue $289M$289MFY2023FY2024: net loss $145M on revenue $259M$259MFY2024FY2025: net loss $131M on revenue $186M$186MFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-09
  • 2026-10-09Chief Executive OfficerTax withholding-29,250$217.3K
  • 2026-10-01Chief Financial OfficerTax withholding-5,465$41.8K
  • 2026-09-09Chief Executive OfficerTax withholding-29,250$214.1K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Maravai LifeSciences Holdings, Inc. do?

Maravai LifeSciences is a life sciences company that provides products and services to support the development of drugs, therapeutics, vaccines, and diagnostics.

When did MRVI last file with the SEC?

Maravai LifeSciences Holdings, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-03. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 15:50 UTC. This page is also available as JSON at /api/data?ticker=MRVI and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for MRVI and 5,000+ tickers.

Create a free account — keep MRVI
For your agent
GET /api/data?ticker=MRVI

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt